Population pharmacokinetics of ganciclovir after intravenous ganciclovir and oral valganciclovir administration in solid organ transplant patients infected with cytomegalovirus.

Caldés, A; Colom, H; Armendariz, Y; Garrido, M J; Troconiz, I F; Gil-Vernet, S; Lloberas, N; Pou, L; Peraire, C; Grinyó, J M

Caldés, A; Colom, H; Armendariz, Y; Garrido, M J; Troconiz, I F; Gil-Vernet, S; Lloberas, N; Pou, L; Peraire, C; Grinyó, J M.

Affiliation

Caldés A; Nephrology Service, Hospital Universitari de Bellvitge, Barcelona, Spain.

Antimicrob Agents Chemother ; 53(11): 4816-24, 2009 Nov.

Article in En | MEDLINE | ID: mdl-19738014

Subject(s)

Antiviral Agents/pharmacokinetics; Ganciclovir/analogs & derivatives; Ganciclovir/pharmacokinetics; Organ Transplantation/adverse effects; Administration, Oral; Adult; Aged; Area Under Curve; Cytomegalovirus Infections/drug therapy; Female; Ganciclovir/administration & dosage; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Prospective Studies; Valganciclovir

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Ganciclovir / Organ Transplantation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Antimicrob Agents Chemother Year: 2009 Document type: Article Affiliation country: Spain Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google